FERRIC CARBOXYMALTOSE
Description:
Ferric carboxymaltose is an iron replacement medication used to treat iron deficiency anemia in adults. It is administered through injections and is produced by the manufacturer EMCURE. This medication comes in the form of vials with an Actual MRP of Rs. 2954. However, it is available at a discounted price of Rs. 2235, offering a discount of 24.34%.
Active Ingredients:
The active ingredient in Ferric Carboxymaltose is ferric iron complexed with carboxymaltose.
Pharmacological Properties:
Ferric carboxymaltose works by replenishing iron stores in the body, which is essential for the production of hemoglobin and red blood cells. It is a complex of iron (III) hydroxide with carboxymaltose, allowing for a controlled release of iron.
Indications:
Ferric carboxymaltose is indicated for the treatment of iron deficiency anemia in adults who have:
– Inadequate oral iron intake or absorption
– Intolerance to oral iron
– Unsuccessful treatment with oral iron
– Chronic kidney disease requiring hemodialysis
Contraindications:
This medication is contraindicated in patients with:
– Known hypersensitivity to ferric carboxymaltose or any of its components
– Anemia not caused by iron deficiency
– Evidence of iron overload or disturbances in iron utilization
Dosage:
The dosage of ferric carboxymaltose is individualized based on a patient’s iron status and body weight. It is typically administered as a slow intravenous injection or infusion under medical supervision.
Side Effects:
Common side effects of ferric carboxymaltose may include:
– Nausea
– Headache
– Dizziness
– Hypotension
– Phlebitis at the injection site
– Diarrhea
It is important to report any severe or persistent side effects to a healthcare provider.
Drug Interactions:
Ferric carboxymaltose may interact with certain medications, such as:
– Oral iron supplements
– Antacids
– Cholestyramine
– Proton pump inhibitors
It is essential to inform your healthcare provider about all medications you are taking before starting ferric carboxymaltose.
Patient Counseling:
Patients receiving ferric carboxymaltose should be counseled on the following:
– Importance of completing the full course of treatment
– Possible side effects and when to seek medical help
– Dietary modifications to enhance iron absorption
– Follow-up appointments to monitor response to treatment
Clinical Evidence:
Clinical studies have demonstrated the efficacy and safety of ferric carboxymaltose in treating iron deficiency anemia in adult patients. The medication has shown to improve hemoglobin levels and quality of life in individuals with iron deficiency.
Frequently Asked Questions:
1. How soon can I expect to see improvement in my symptoms after starting ferric carboxymaltose?
Most patients experience an improvement in their symptoms within a few weeks of starting treatment with ferric carboxymaltose. However, individual responses may vary.
2. Can ferric carboxymaltose be administered at home or does it require a healthcare setting?
Ferric carboxymaltose is typically administered in a healthcare setting, such as a clinic or hospital, under the supervision of a healthcare provider.
3. Are there any dietary restrictions I need to follow while taking ferric carboxymaltose?
Patients taking ferric carboxymaltose may be advised to consume a diet rich in iron-rich foods to support iron absorption. It is recommended to avoid taking calcium-rich foods or beverages at the same time as the medication.
4. What should I do if I miss a dose of ferric carboxymaltose?
If you miss a dose of ferric carboxymaltose, contact your healthcare provider to determine the best course of action. Do not double the dose to make up for a missed dose.
5. Can ferric carboxymaltose be safely used during pregnancy or breastfeeding?
The use of ferric carboxymaltose during pregnancy or breastfeeding should be carefully considered and discussed with a healthcare provider. They will assess the potential benefits and risks before recommending its use.
Conclusion:
In conclusion, ferric carboxymaltose is a valuable medication for the treatment of iron deficiency anemia in adults. It provides a convenient and effective option for patients who cannot tolerate or absorb oral iron supplements. By understanding its active ingredients, pharmacological properties, indications, contraindications, dosage, side effects, and drug interactions, patients can make informed decisions in collaboration with their healthcare providers for optimal treatment outcomes. The clinical evidence supports the efficacy and safety of ferric carboxymaltose, offering a promising solution for individuals suffering from iron deficiency anemia.
